This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q31802549
rdf:type
wikibase:Item
schema:description
2001年學術文章 2001 nî lūn-bûn наукова стаття, опублікована в січні 2001 bài báo khoa học мақолаи илмӣ 2001 թվականի հունվարին հրատարակված գիտական հոդված научни чланак wissenschaftlicher Artikel 2001年学术文章 2001年學術文章 vedecký článok vědecký článek научна статия επιστημονικό άρθρο 2001년 논문 mokslinis straipsnis научни чланак artikull shkencor מאמר מדעי บทความทางวิทยาศาสตร์ ২০০১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2001年学术文章 2001年學術文章 artykuł naukowy artigo científico 2001年学术文章 2001年學術文章 artigo científico (publicado na 2001) vetenskaplig artikel vitenskapelig artikkel articolo scientifico videnskabelig artikel (udgivet 2001) 2001年學術文章 bilimsel makale tudományos cikk мақолаи илмӣ سائنسی مضمون 2001年学术文章 2001年學術文章 article científic wetenschappelijk artikel article scientific مقالة علمية: نشرت في عام 2001 مقالهٔ علمی 2001年の論文 სამეცნიერო სტატია teaduslik artikkel artigo científico (publicado na 2001) artículo científico publicado en 2001 article scientifique (publié 2001) scientific article tieteellinen artikkeli naučni članak vitskapeleg artikkel научная статья 2001年学术文章 2001 թուականի Յունուարին հրատարակուած գիտական յօդուած scienca artikolo artikulong pang-agham articol științific artículu científicu espublizáu en 2001
p:P577
wds:Q31802549-500E0652-7C52-401A-80D5-42E5E0DB031D
wdt:P577
2001-01-01T00:00:00Z
p:P2860
wds:Q31802549-5128EC17-0367-4870-9899-03250C6EE7C3 wds:Q31802549-60592DF3-3D86-4316-B47A-7F22BC6E7D18 wds:Q31802549-63DF5236-39AB-4E69-B2B0-C16E64AA81D7 wds:Q31802549-1E18B836-B9CD-4C69-9CBE-FA1143C14C20 wds:Q31802549-343FAD48-A44A-41F2-B3F8-F8E4FB959106 wds:Q31802549-1832405C-84B5-4E1E-943E-DDA858FF5CF3 wds:Q31802549-F0C67D29-5219-4B5F-9897-B4F1EC8355F6 wds:Q31802549-968482FA-AF0B-4A38-BB7E-12642E0BFF29 wds:Q31802549-7380FAB0-A4EF-4F97-B880-77FD63B59B9E wds:Q31802549-749C8941-7510-487D-A01F-DCB7E7C35919 wds:Q31802549-7DA10165-FD68-492C-85AC-1A84B78AFDB2 wds:Q31802549-806F3917-9F41-446F-B3E3-8374F4B9EF32
wdt:P2860
wd:Q33672750 wd:Q74533282 wd:Q33735280 wd:Q43102413 wd:Q74673404 wd:Q44063120 wd:Q77760906 wd:Q24564047 wd:Q50537907 wd:Q54237890 wd:Q39842759 wd:Q36528150
p:P2093
wds:Q31802549-C12E1A40-BC8E-4660-B78E-8DAAE47EF1B8 wds:Q31802549-C4E4B62A-AB41-4818-B8DE-6CCC580A070E wds:Q31802549-338FD31B-C3AE-4E36-84B1-70CF6B16D914
wdt:P2093
Mooney L Denton M Kerr KG
rdfs:label
Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients
skos:prefLabel
Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients
schema:name
Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients
p:P1476
wds:Q31802549-B2B40026-C2EA-46C5-9E40-996C4AD83155
wdt:P1476
Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients
p:P304
wds:Q31802549-A974BBA9-EDD9-4393-BE70-D56FD0E0108A
wdt:P304
63-66
p:P31
wds:Q31802549-E303C6BD-40F5-456D-AB54-85A0F5C52379
wdt:P31
wd:Q13442814
p:P921
wds:Q31802549-91241635-C5C1-465B-B9F5-4DFF67A1A99D wds:Q31802549-BEFF7809-05C7-45F5-A89A-E9DA691D1DEA wds:Q31802549-F17302F3-4543-4B4F-87FB-E663938B8F2D
wdt:P921
wd:Q142705 wd:Q104541 wd:Q178194
p:P698
wds:Q31802549-94876EB7-A5F5-48F9-8E54-9D310105C636
wdtn:P698
n9:11137651
wdt:P698
11137651
p:P1433
wds:Q31802549-0CF6ED76-D085-4E0C-B5B0-8F79443B26F0
wdt:P1433
wd:Q15724616
p:P433
wds:Q31802549-E4C4DCC9-F87B-494B-9E5E-22088EE74655
p:P478
wds:Q31802549-C8C8C072-BA9A-4476-94D9-5D88FFE6202F
wdt:P433
1
wdt:P478
17
p:P356
wds:Q31802549-6C6A0E0C-151E-424F-AD0F-9858972F606F
wdtn:P356
n12:S0924-8579(00)00307-1
wdt:P356
10.1016/S0924-8579(00)00307-1